Primaquine decreased plasma concentration of ritonavir: single- and repeated-dose study in Sprague Dawley rats.
Louisa, Melva; Soetikno, Vivian; Nafrialdi, Nafrialdi; Setiabudy, Rianto; Suyatna, Frans D.
Artigo em Inglês | IMSEAR | ID: sea-148893
Documentos relacionados
Co-administration of ritonavir and primaquine decreases plasma concentration of primaquine: single- and multiple-dose study in the rats.
Targeting Apoptosis Signal-Regulating Kinase-1 (ASK-1) As a Biomarker of Monocrotaline-Induced Pulmonary Hypertension following Administration of Antiretroviral Medications in Rat Model.
Drug-drug interactions and dose management of BTK inhibitors when initiating nirmatrelvir/ritonavir (paxlovid) based on physiologically-based pharmacokinetic models.
Paritaprevir and Ritonavir Liver Concentrations in Rats as Assessed by Different Liver Sampling Techniques.
Tafenoquine following G6PD screening versus primaquine for the treatment of vivax malaria in Brazil: A cost-effectiveness analysis using a transmission model.
[Dual regulation of Qizhiweitong particles on gastric motility in the model rats with gastroparesis].
[Effects of titanium dioxide nanoparticles on fecal metabolome in rats after oral administration for 90 days].
The effect of ritonavir on the pharmacokinetics of clonidine in vivo and in vitro.
[ST266 inhibits neointimal hyperplasia after arterial balloon injury in rats].
Safety of single-dose primaquine as a Plasmodium falciparum gametocytocide: a systematic review and meta-analysis of individual patient data.